$49,045,600.00 of the payment will go to Medicaid programs to resolve civil allegations that Gilead’s unlawful promotion of the Gilead HIV Drugs caused false claims to be submitted to the government health care programs. These benefits were alleged to have been provided to practitioners to induce them to prescribe the Gilead HIV Drugs in violation of the Anti-Kickback Statute, 42 U.S.C. These unlawful benefits caused false claims for the Gilead HIV Drugs to be submitted to, and paid by, the State’s Medicaid program in violation of the State’s false claims act. 16-CV-6228 (PAE) was filed in the United States District Court for the Southern District of New York under the federal False Claims Act and various state false claims statutes. It is responsible for investigating and prosecuting Medicaid fraud, abuse, neglect, and financial exploitation of patients in any facility that accepts Medicaid funds.